WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001030818) A NOVEL POLYPEPTIDE-RNA BINDING PROTEIN 33 AND POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2001/030818 International Application No.: PCT/CN2000/000323
Publication Date: 03.05.2001 International Filing Date: 16.10.2000
Chapter 2 Demand Filed: 21.05.2001
IPC:
A61K 38/00 (2006.01) ,C07K 14/47 (2006.01)
Applicants: MAO, Yumin[CN/CN]; CN (UsOnly)
XIE, Yi[CN/CN]; CN (UsOnly)
SHANGHAI BIO ROAD GENE DEVELOPMENT LTD.[CN/CN]; 3rd Building, 12th floor No. 1111 Zhongshan Bei Er Road Shanghai 200092, CN (AllExceptUS)
Inventors: MAO, Yumin; CN
XIE, Yi; CN
Agent: SHANGHAI ZHI XIN PATENT AGENT LTD.; 10/F, Italy Building 446 Zhao Jia Bang Road Shanghai 200031, CN
Priority Data:
99 1 19821.222.10.1999CN
Title (EN) A NOVEL POLYPEPTIDE-RNA BINDING PROTEIN 33 AND POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE
(FR) NOUVEAU POLYPEPTIDE, PROTEINE DE LIAISON 33 A L'ARN, ET POLYNUCLEOTIDE CODANT POUR CE POLYPEPTIDE
Abstract:
(EN) The invention discloses a new kind of RNA binding protein 33 and polynucleotide encoding the polypeptide and a process for producing the polypeptide by recombinant methods. It also discloses the method of applying the polypeptide for the treatment of various kinds of diseases, such as cancer, hemopathology, HIV infection, immune diseases and inflammation. The antibody and antagonist of the polypeptide and the therapeutic use of the same is also disclosed. In addition, it refers to the use of polynucleotide encoding said RNA binding protein 33.
(FR) L'invention concerne un nouveau polypeptide, une protéine de liaison 33 à l'ARN, et un polynucléotide codant pour ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment des tumeurs malignes, de l'hémopathie, de l'infection par VIH, de maladies immunitaires et de diverses inflammations. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant pour la protéine de liaison 33 à l'ARN.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG)
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)